{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:29:02Z","timestamp":1793964542948,"version":"4.8.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":68,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah bint Abdulrahman University","doi-asserted-by":"publisher","award":["PNURSP2026R774"],"award-info":[{"award-number":["PNURSP2026R774"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinsp.2026.100908","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:56:25Z","timestamp":1774947385000},"page":"100908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cardiac safety of sofosbuvir-based direct-acting antivirals in hepatitis C patients with pre-existing heart disease"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2901-2614","authenticated-orcid":false,"given":"Amr Shaaban","family":"Hanafy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5967-5315","authenticated-orcid":false,"given":"Mohamed Sorour","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8351-3097","authenticated-orcid":false,"given":"Osama","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3588-796X","authenticated-orcid":false,"given":"Ayman Fathy Elsayed","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1947-9555","authenticated-orcid":false,"given":"Ahmad M.","family":"Hassaneen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2176-7182","authenticated-orcid":false,"given":"Rania","family":"Naguib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1994-2570","authenticated-orcid":false,"given":"Eslam Kamal","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1778-1631","authenticated-orcid":false,"given":"Hany A.","family":"Elkattawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clinsp.2026.100908_bib0001","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/cells8101249","article-title":"Mechanisms underlying hepatitis C virus-associated hepatic fibrosis","volume":"8","author":"Khatun","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.clinsp.2026.100908_bib0002","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/pathogens13040339","article-title":"Chronic hepatitis C virus infection, extrahepatic disease and the impact of new direct-acting antivirals","volume":"13","author":"M\u00e9ndez-S\u00e1nchez","year":"2024","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.clinsp.2026.100908_bib0003","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cardfail.2005.11.004","article-title":"Myocarditis and heart failure associated with hepatitis C virus infection","volume":"12","author":"Matsumori","year":"2006","journal-title":"J Card Fail"},{"issue":"7","key":"10.1016\/j.clinsp.2026.100908_bib0004","doi-asserted-by":"crossref","first-page":"618","DOI":"10.26719\/2018.24.7.618","article-title":"Association between coronary artery disease and hepatitis C virus seropositivity","volume":"24","author":"Shoeib","year":"2018","journal-title":"East Mediterr Health J"},{"issue":"6","key":"10.1016\/j.clinsp.2026.100908_bib0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/14779072.2021.1917383","article-title":"Diagnosis and treatment of HCV heart diseases","volume":"19","author":"Haykal","year":"2021","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100908_bib0006","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/v16030365","article-title":"A review on the pathogenesis of cardiovascular disease of Flaviviridea Viruses infection","volume":"16","author":"Yang","year":"2024","journal-title":"Viruses"},{"issue":"42","key":"10.1016\/j.clinsp.2026.100908_bib0007","doi-asserted-by":"crossref","first-page":"15492","DOI":"10.3748\/wjg.v20.i42.15492","article-title":"Cirrhotic cardiomyopathy: a cardiologist's perspective","volume":"20","author":"Gassanov","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinsp.2026.100908_bib0008","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijcard.2020.11.017","article-title":"Effect of liver transplantation on QT-interval prolongation and impact on mortality","volume":"326","author":"Ko","year":"2021","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.clinsp.2026.100908_bib0009","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.amjcard.2018.08.045","article-title":"Effects of hepatitis C Virus antibody-positivity on cardiac function and long-term prognosis in patients with adult congenital heart disease","volume":"122","author":"Konno","year":"2018","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100908_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s43044-020-0042-y","article-title":"Effect of direct-acting antivirals on corrected QT interval and cardiac functions in patients with chronic hepatitis C virus infection","volume":"72","author":"Ibrahim","year":"2020","journal-title":"Egypt Heart J"},{"issue":"6","key":"10.1016\/j.clinsp.2026.100908_bib0011","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.07.051","article-title":"Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge","volume":"149","author":"Renet","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100908_bib0012","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s40264-017-0586-2","article-title":"Cardiac harms of sofosbuvir: systematic review and meta-analysis","volume":"41","author":"Caldeira","year":"2018","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100908_bib0013","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2015.09.007","article-title":"Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies","volume":"150","author":"Petta","year":"2016","journal-title":"Gastroenterology"},{"issue":"17","key":"10.1016\/j.clinsp.2026.100908_bib0014","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/ajhp\/zxz127","article-title":"Decreased warfarin sensitivity among patients treated with elbasvir and grazoprevir for hepatitis C infection","volume":"76","author":"DeCarolis","year":"2019","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100908_bib0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1345\/aph.1G407","article-title":"Increased sensitivity to warfarin after heart valve replacement","volume":"40","author":"Rahman","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.clinsp.2026.100908_bib0016","doi-asserted-by":"crossref","first-page":"661","DOI":"10.21037\/hbsn.2020.01.05","article-title":"FIB-4 score and hepatocellular carcinoma risk after hepatitis C virus cure: time to revise surveillance?","volume":"9","author":"Saviano","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.clinsp.2026.100908_bib0017","first-page":"49","article-title":"Liver stiffness: a novel parameter for the diagnosis of liver disease","volume":"2","author":"Mueller","year":"2010","journal-title":"Hepat Med"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100908_bib0018","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1213\/ANE.0000000000003807","article-title":"Grade 3 echocardiographic diastolic dysfunction is associated with increased risk of major adverse cardiovascular events after surgery: a retrospective cohort study","volume":"129","author":"Zhou","year":"2019","journal-title":"Anesth Analg"},{"issue":"9","key":"10.1016\/j.clinsp.2026.100908_bib0019","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1007\/s11999-008-0346-9","article-title":"Statistics in brief: the importance of sample size in the planning and interpretation of medical research","volume":"466","author":"Biau","year":"2008","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100908_bib0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jmv.25314","article-title":"Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C-infected patients with thalassemia","volume":"91","author":"Khosravi","year":"2019","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.clinsp.2026.100908_bib0021","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1128\/AAC.00668-13","article-title":"Echocardiogram study to evaluate the effect of the novel hepatitis C virus NS5A inhibitor GSK2336805 on cardiac contractility in healthy subjects","volume":"57","author":"Wilfret","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100908_bib0022","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cardfail.2019.08.014","article-title":"Biering-S\u00f8rensen T. left atrial function determined by echocardiography predicts incident heart failure in patients with STEMI treated by primary percutaneous coronary intervention","volume":"26","author":"Modin","year":"2020","journal-title":"J Card Fail"},{"issue":"7","key":"10.1016\/j.clinsp.2026.100908_bib0023","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00392-017-1086-1","article-title":"High incidence of cardiac dysfunction and response to antiviral treatment in patients with chronic hepatitis C virus infection","volume":"106","author":"Poller","year":"2017","journal-title":"Clin Res Cardiol"},{"issue":"Suppl 4","key":"10.1016\/j.clinsp.2026.100908_bib0024","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.47391\/JPMA.EGY-S4-27","article-title":"Evaluation of left ventricular function after sofosbuvir and daclatasvir regimen for chronic hepatitis C","volume":"73","author":"Maher","year":"2023","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.clinsp.2026.100908_bib0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s43066-021-00133-4","article-title":"B-type natriuretic peptide (BNP) in HCV-positive egyptian patients: the impact of HCV eradication on plasma BNP levels","volume":"11","author":"Nada","year":"2021","journal-title":"Egypt Liver J"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100908_bib0026","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s12020-012-9688-x","article-title":"Association between chronic hepatitis C virus infection and high levels of circulating N-terminal pro-brain natriuretic peptide","volume":"43","author":"Okada","year":"2013","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100908_bib0027","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s40264-017-0586-2","article-title":"Cardiac harms of sofosbuvir: systematic review and meta-analysis","volume":"41","author":"Caldeira","year":"2018","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.clinsp.2026.100908_bib0028","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.dld.2018.09.012","article-title":"Is sofosbuvir\/ledipasvir safe for the hearts of children with hepatitis C virus?","volume":"51","author":"Ghobrial","year":"2019","journal-title":"Dig Liver Dis"},{"issue":"Suppl 1","key":"10.1016\/j.clinsp.2026.100908_bib0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000451010","article-title":"Outcome of combination therapy with sofosbuvir and ledipasvir for chronic type C liver disease","volume":"92","author":"Hagiwara","year":"2017","journal-title":"Oncology"},{"issue":"7","key":"10.1016\/j.clinsp.2026.100908_bib0030","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2169\/internalmedicine.56.7948","article-title":"Ventricular tachycardia as a complication of ledipasvir and sofosbuvir treatment for HCV infection","volume":"56","author":"Nirei","year":"2017","journal-title":"Intern Med"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226000499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226000499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:16:17Z","timestamp":1793963777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593226000499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"alternative-id":["S1807593226000499"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.100908","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac safety of sofosbuvir-based direct-acting antivirals in hepatitis C patients with pre-existing heart disease","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.100908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100908"}}